Berg Insight: Number of remotely monitored patients to reach 36.1M by 2020
The two main applications are monitoring of patients with implantable cardiac rhythm management devices and monitoring of patients with sleep therapy devices.
Validic, higi team-up over remote patient monitoring
Integration between the two platforms provides comprehensive health data access for healthcare organizations seeking to develop innovative treatments.
Presence Pro Care with a number of sensors and features launches on Indiegogo
The system offers monitoring capabilities for caregivers, messaging, emergency response integration, wellness challenges, medication reminders and more.
Reflexion Health’s remote monitoring tool for physical therapy clears the FDA
Called Vera, it is designed to help people recovering from injuries do their physical therapy from home, while allowing therapists to collect patients' data.
Capsule’s patient monitoring system clears the FDA
Called SmartLinx Vitals Plus, the solution integrates vital signs monitoring, documentation and connectivity in a single device.
Leaf Healthcare raises $3.3M for its patient monitoring sensors
The company makes a wireless monitor that tracks patient position and movement which can be used to alert nursing staff as to which patients need to be moved.
Owlet Baby Care secures $7M for its Smart Sock baby monitor
Launching this fall, the Owlet Baby Monitor tracks an infant's vital signs like heart rate and oxygen levels to alert parents if their baby stops breathing.
InfoBionic raises $8M for its remote monitoring device
The funds will be used to commercialize the second generation of the MoMe Kardia device that transmits a continuous feed of the patient's heart rhythm.
FDA clears PhysIQ’s Personalized Physiology Analytics Engine Software
It is the first FDA-cleared product to receive the code PLB: Automated calculation of a summary index based on several individual measured vital sign inputs.
FDA greenlights Sentrian’s Remote Patient Intelligence solution
Sentrian's RPI is not subject to further FDA regulatory requirements at this time, and the company can immediately begin marketing its solution in the U.S.